Minimal Change Disease
📧 Sign up to get email alerts when something new happens for Minimal Change Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS) [NA]
A pilot trial evaluating transcutaneous auricular vagus nerve stimulation (taVNS) for steroid-resistant nephrotic syndrome in children is cu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: taVNS for FRNS in Children [NA]
This clinical trial update notes that taVNS (transcutaneous auricular vagus nerve stimulation) is being studied for frequently relapsing nep…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease [Phase 2]
Phase 2 clinical trial evaluating Frexalimab, Brivekimig, or Rilzabrutinib for primary focal segmental glomerulosclerosis or minimal change …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis [Phase 2, Phase 3]
A Phase 2/3 clinical trial assessing BAT4406F injection in adults with Minimal Change Disease and Focal Segmental Glomerulosclerosis is curr…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of WAL0921 in Patients With Glomerular Kidney Diseases [Phase 2]
Walden Biosciences reports a Phase 2 clinical trial of WAL0921 in multiple glomerular diseases, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and PK of SK-09 [Phase 1]
A Phase 1 study is evaluating the safety, tolerability and pharmacokinetics of SK-09 for focal segmental glomerulosclerosis and minimal chan…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: NEPTUNE Match Study [NA]
The NEPTUNE Match Study is currently recruiting, focusing on nephrotic syndrome in children and related glomerular diseases such as focal se…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Atacicept in Multiple Glomerular Diseases [Phase 2]
Phase 2 clinical trial evaluating atacicept in multiple glomerular diseases is currently recruiting, including primary membranous nephropath…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases [Phase 2]
Travere Therapeutics is running a phase 2 pediatric trial of sparsentan for proteinuric glomerular diseases, including Focal Segmental Glome…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
This clinical trial update describes an interview study of adult and pediatric patients with swelling due to nephrotic syndrome and of paren…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
The FOrMe Registry is a Germany-based registry for focal segmental glomerulosclerosis and minimal change disease, currently recruiting to co…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
An observational study at the University of Michigan is evaluating recurrence after kidney transplantation in patients with focal segmental …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Nephrotic Syndrome Study Network
Clinical trial update from the Nephrotic Syndrome Study Network indicating that the study is currently recruiting for conditions including M…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy [Phase 4]
Phase 4 trial evaluating Active Vitamin D with reduced-dose prednisolone for Minimal Change Disease and Nephrotic Syndrome; the study has co…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease [Phase 2]
A Phase 2 clinical trial evaluating tumor necrosis factor inhibition for focal segmental glomerulosclerosis and treatment-resistant minimal …
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD [Phase 3]
A Phase 3 clinical trial is planned to evaluate tacrolimus in combination with rituximab as initial therapy for Minimal Change Disease; the …
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease [Phase 4]
Phase 4 trial comparing tacrolimus to prednisolone for minimal change disease has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) [Phase 2]
Phase 2 pilot study evaluating abatacept for safety and efficacy in adults and children 6+ with nephrotic syndrome due to FSGS or minimal ch…
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome [Phase 3]
A Phase 3 trial compares rituximab to continued corticosteroid treatment in idiopathic nephrotic syndrome, including minimal change disease …
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Valproic Acid for Idiopathic Nephrotic Syndrome [Phase 2, Phase 3]
Clinical trial update on valproic acid for idiopathic nephrotic syndrome, with Phase 2 and Phase 3, including mention of focal segmental glo…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome [Phase 4]
This document provides a Phase 4 clinical trial update on adjusted steroids therapy for children with idiopathic nephrotic syndrome due to m…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) [Phase 3]
Phase 3 clinical trial update for rituximab in multirelapsing minimal change disease or focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated tacrolimus in combination with low-dose corticosteroid for adults with Minimal Change Disease and has c…